Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules. Department of Urogynaecology, King's College Hospital, London.
Stevenson
J C
JC
Department of Urogynaecology, King's College Hospital, London.
Gaspard
U
U
Avouac
B
B
Bricaire
C
C
Cardozo
L
L
Collins
P
P
Devogelaer
J P
JP
Dören
M
M
Gennari
C
C
Kaufman
J M
JM
Kuttenn
F
F
Ringe
J D
JD
Scarafiotti
C
C
Vanhaelst
L
L
Zichella
L
L
Ziegler
R
R
Reginster
J Y
JY
D003327:Coronary Disease / Q000517:prevention & control; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005831:Genital Diseases, Female / Q000517:prevention & control; D006801:Humans; D011788:Quality of Life; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage / Q000627:therapeutic use*; D014570:Urologic Diseases / Q000517:prevention & control
D004967:Estrogens; D020845:Selective Estrogen Receptor Modulators